Cargando…

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

Ifosfamide is an alkylating agent used in the treatment of a variety of solid tumours. Ten to 15% of patients treated with ifosfamide develop an encephalopathy. Methylene blue (MB) may be used in the treatment of this encephalopathy. The purpose of this study was to evaluate the neuroprotective effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pelgrims, J, Vos, F De, Brande, J Van den, Schrijvers, D, Prové, A, Vermorken, J B
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363270/ https://www.ncbi.nlm.nih.gov/pubmed/10646879 http://dx.doi.org/10.1054/bjoc.1999.0917

Ejemplares similares

Ifosfamide-Induced Encephalopathy Successfully Prevented by Methylene Blue: A Pediatric Case Report and Review of the Literature
por: Furui, Yu, et al.
Publicado: (2023)

Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue
por: Vakiti, Anusha, et al.
Publicado: (2018)

A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature
por: Chain, Gabriel, et al.
Publicado: (2022)

Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue
por: Snyder, Matthew, et al.
Publicado: (2017)

Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report
por: Hamilton, Juliette E., et al.
Publicado: (2020)

A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours
por: Rasschaert, M, et al.
Publicado: (2007)

Paint It Blue: Methylene Blue in Burn Care
por: Goodenough, Christopher J., et al.
Publicado: (2020)

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant?
por: Séjourné, Alice, et al.
Publicado: (2014)

Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study
por: Skinner, R, et al.
Publicado: (2000)

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.
por: Pronk, L. C., et al.
Publicado: (1998)

Methylene Blue: Revisited
por: Ginimuge, Prashant R., et al.
Publicado: (2010)

Methylene-Blue in Fevers
por: Frost, G. H.
Publicado: (1908)

Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
por: Michelagnoli, M P, et al.
Publicado: (1999)

Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females
por: Zanetta, G, et al.
Publicado: (1999)

Management of nitrobenzene poisoning with oral methylene blue and vitamin C in a resource limited setting: A case report
por: Shrestha, Ninadini, et al.
Publicado: (2020)

Risk Factors for Ifosfamide-Related Encephalopathy in Adult Cancer Patients: An Integrative Review
por: Lee Brink, Amanda, et al.
Publicado: (2020)

Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
por: Kosmas, C, et al.
Publicado: (2000)

Methylene blue unresponsive methemoglobinemia
por: Patnaik, Sibabratta, et al.
Publicado: (2014)

Methylene blue unresponsive methemoglobinemia
por: Mirakbari, Seyed Mostafa
Publicado: (2014)

Russo's Methylene Blue Reaction
por: Rankin, T. Thomson
Publicado: (1912)

Methylene Blue in the Treatment of Cholera
por: Bryan, John
Publicado: (1952)

Methylene blue in covid-19
por: Scigliano, Giulio, et al.
Publicado: (2021)

COVID-19 and Methylene Blue
por: Wiwanitkit, Viroj
Publicado: (2021)

Methylene Blue in the Treatment of Cancer
por: Slack, Henry R.
Publicado: (1907)

Methylene Blue in Pulmonary Tuberculosis
Publicado: (1901)

Methylene Blue in Refractory Shock
por: Chalise, Som N, et al.
Publicado: (2022)

The Methylene Blue Reaction of Russo in Enteric Fever
por: Rolleston, J. D.
Publicado: (1906)

Methylene blue: Subduing the post COVID-19 blues!
por: Magoon, Rohan, et al.
Publicado: (2021)

THE PHOTODYNAMIC INACTIVATION OF PHAGE PRECURSOR BY METHYLENE BLUE
por: Krueger, A. P., et al.
Publicado: (1940)

Use of methylene blue in the prevention of recurrent intra-abdominal postoperative adhesions
por: Neagoe, Octavian C., et al.
Publicado: (2017)

Methylene Blue Prevents Retinal Damage Caused by Perinatal Asphyxia in the Rat
por: Fernández, Juan Carlos, et al.
Publicado: (2020)

Ifosfamide-induced Encephalopathy Precipitated by Aprepitant: A Rarely Manifested Side Effect of Drug Interaction
por: Kataria, Pritam Sureshchandra, et al.
Publicado: (2017)

THE SELECTIVE BACTERICIDAL ACTION OF METHYLENE-BLUE
por: Churchman, John W.
Publicado: (1913)

Methylene Blue in the Cure of Ulcerative Stomatitis
Publicado: (1909)

On the Use of Methylene Blue in Malarial Fevers
por: Marshall, D. G., et al.
Publicado: (1893)

METHYLENE BLUE IN REFRACTORY SEPTIC SHOCK
por: Eliliwi, Mouhanned, et al.
Publicado: (2020)

Bile salt induced solubilization of methylene blue: Study on methylene blue fluorescence properties and molecular mechanics calculation
por: Selvam, Susithra, et al.
Publicado: (2017)

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
por: Sculier, J-P, et al.
Publicado: (2000)

Complications of Methylene Blue Dye in Breast Surgery: Case Reports and Review of the Literature
por: Reyes, FJ, et al.
Publicado: (2010)

Novel management of methylene blue extravasation: A case report and review of literature
por: Khokhar, Rashid Saeed, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_srevsv2a04blfkl69mchh4el77